rosiglitazone has been researched along with Chronic Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (52.63) | 29.6817 |
| 2010's | 9 (47.37) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YQ; Chen, WM; Lin, J; Liu, J; Sun, PH; Wang, F; Xu, XJ; Zeng, T | 1 |
| Deng, J; Shao, M; Shao, X; Wang, X; Xia, Y; Xiong, C; Zhou, Q; Zou, H | 1 |
| Kang, JY; Kim, YK; Kwon, SS; Lee, HY; Lee, SY; Park, CK; Rhee, CK; Yoon, HK | 1 |
| Apgar, BS | 1 |
| Caboni, P; Carboni, E; Carta, AR; Frau, L; Garau, A; Ibba, M; Schintu, N | 1 |
| Bland, JM; Hart, CM; Kleinhenz, DJ; Mitchell, PO; Nisbet, RE; Sutliff, RL; Walp, ER | 1 |
| Chapman, AC; Cipolla, MJ; Roberts, TJ | 1 |
| Chaiyakunapruk, N; Cheewasithirungrueng, N; Dilokthornsakul, P; Jeanpeerapong, N; Nimpitakpong, P; Srisupha-olarn, W; Thanarungroj, A | 1 |
| Ledford, CJ | 1 |
| Ambalavanan, N; Bulger, A; Chen, YF; Halloran, B; James, ML; Nicola, T; Olave, N; Oparil, S; Rehan, V; Zhang, W | 1 |
| Aimaretti, G; Cittadini, A; Isgaard, J; Longobardi, S; Monti, MG; Napoli, R; Netti, PA; Rea, D; Saccà, L; Samà, M; Walser, M | 1 |
| Barut, F; Jakubowska-Dogru, E; Ozacmak, VH; Sayan-Ozacmak, H | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F | 1 |
| Carabello, BA; De Freitas, G; Ishiyama, M; Nemoto, S; Razeghi, P; Taegtmeyer, H | 1 |
| Füchtenbusch, M; Löbner, K | 1 |
| Biery, JC; Goins, JA; Lee, TA; Marceille, JR; Soni, R | 1 |
| Alarcón De La Lastra, C; Martín, AR; Sánchez-Hidalgo, M; Villegas, I | 1 |
| Bonyhay, L; Ratziu, V; Tahiri, M | 1 |
| Barker, JN; Daly, S; Ellis, CN; Haig, AE; Jayawardene, DA; Parker, CA | 1 |
2 review(s) available for rosiglitazone and Chronic Disease
| Article | Year |
|---|---|
[Inflammation and diabetes].
Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Arteriosclerosis; Aspirin; Blood Glucose; Body Weight; C-Reactive Protein; Chronic Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Exercise; Humans; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Inflammation; Inflammation Mediators; Insulin; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Metabolic Syndrome; Obesity; Research; Risk Factors; Rosiglitazone; Thiazolidinediones | 2004 |
[Nonalcoholic steatohepatitis].
Topics: Chronic Disease; Fatty Liver; Humans; Inflammation; Liver; Necrosis; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vasodilator Agents; Vitamin E Deficiency | 2005 |
1 trial(s) available for rosiglitazone and Chronic Disease
| Article | Year |
|---|---|
Placebo response in two long-term randomized psoriasis studies that were negative for rosiglitazone.
Topics: Adolescent; Adult; Aged; C-Reactive Protein; Chronic Disease; Dermatologic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebo Effect; Psoriasis; Rosiglitazone; Severity of Illness Index; Thiazolidinediones | 2007 |
16 other study(ies) available for rosiglitazone and Chronic Disease
| Article | Year |
|---|---|
4-arylamidobenzyl substituted 5-bromomethylene-2(5H)-furanones for chronic bacterial infection.
Topics: 4-Butyrolactone; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Chronic Disease; Humans; Lipopolysaccharides; Male; Mice; Molecular Docking Simulation; NF-kappa B; Nitric Oxide; PPAR gamma; Pseudomonas aeruginosa; Pseudomonas Infections; Quorum Sensing; RAW 264.7 Cells | 2018 |
Protective effect of rosiglitazone on chronic renal allograft dysfunction in rats.
Topics: Animals; Anti-Inflammatory Agents; Chronic Disease; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibrosis; Graft Rejection; Humans; Kidney; Kidney Transplantation; Macrophages; Male; PPAR gamma; Rats; Rats, Inbred Lew; Rosiglitazone; Signal Transduction; Transforming Growth Factor beta | 2019 |
Effect of intranasal rosiglitazone on airway inflammation and remodeling in a murine model of chronic asthma.
Topics: Actins; Administration, Inhalation; Airway Remodeling; Animals; Anti-Asthmatic Agents; Asthma; Chronic Disease; Collagen; Disease Models, Animal; Female; Lung; Mice, Inbred BALB C; NF-kappa B; Ovalbumin; Pneumonia; PPAR gamma; Pulmonary Eosinophilia; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptor 4 | 2016 |
Challenges of fragmented care in long-term management of pelvic pain.
Topics: Acetaminophen; Adult; Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Chronic Disease; Continuity of Patient Care; Cyclohexanecarboxylic Acids; Diagnosis, Differential; Drug Therapy, Combination; Endometriosis; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydrocodone; Hypoglycemic Agents; Interdisciplinary Communication; Pelvic Pain; Risk Factors; Rosiglitazone; Substance-Related Disorders; Thiazolidinediones; Trazodone; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms | 2007 |
PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Catalepsy; CD11b Antigen; Chromatography, High Pressure Liquid; Chronic Disease; Disease Models, Animal; Dopamine; Drug Interactions; Dynorphins; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Globus Pallidus; Locomotion; Male; Mice; Mice, Inbred C57BL; Motor Activity; MPTP Poisoning; PPAR gamma; Psychomotor Performance; RNA, Messenger; Rosiglitazone; Smell; Tandem Mass Spectrometry; Thiazolidinediones; Tyrosine 3-Monooxygenase | 2009 |
Rosiglitazone attenuates chronic hypoxia-induced pulmonary hypertension in a mouse model.
Topics: Animals; Blood Pressure; Cell Proliferation; Chronic Disease; Disease Models, Animal; Gene Expression Regulation; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypoxia; Ligands; Male; Mice; NADPH Oxidase 4; NADPH Oxidases; Organ Size; PPAR gamma; PTEN Phosphohydrolase; Receptor, Platelet-Derived Growth Factor beta; Rosiglitazone; Signal Transduction; Superoxides; Thiazolidinediones; Vasodilator Agents | 2010 |
PPAR-gamma agonist rosiglitazone reverses increased cerebral venous hydraulic conductivity during hypertension.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Brain Edema; Capillary Permeability; Cerebral Veins; Cerebrovascular Circulation; Chronic Disease; Cyclic N-Oxides; Disease Models, Animal; Female; Hydrostatic Pressure; Hypertension; NG-Nitroarginine Methyl Ester; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Spin Labels; Thiazolidinediones; Time Factors | 2009 |
Estimation of financial burden due to oversupply of medications for chronic diseases.
Topics: Aged; Atorvastatin; Chronic Disease; Clopidogrel; Drug Costs; Female; Heptanoic Acids; Hospitals, University; Humans; Male; Middle Aged; Pharmaceutical Preparations; Phenylcarbamates; Pyrroles; Retrospective Studies; Rivastigmine; Rosiglitazone; Tetrazoles; Thailand; Thiazolidinediones; Ticlopidine; Valine; Valsartan | 2012 |
Contending mediated risk messages: a grounded theory of the physician-patient discussion of a prescription medication's changing risk.
Topics: Aged; Chronic Disease; Communication; Diabetes Mellitus, Type 2; Drug Prescriptions; Female; Health Knowledge, Attitudes, Practice; Humans; Hypoglycemic Agents; Male; Patient Education as Topic; Physician-Patient Relations; Physician's Role; Primary Health Care; Risk; Rosiglitazone; Thiazolidinediones | 2011 |
Hypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.
Topics: Airway Remodeling; Animals; Animals, Newborn; Antibodies, Neutralizing; Chronic Disease; Collagen; Hypertrophy, Right Ventricular; Hypoxia; Lung; Mice; Mice, Inbred C57BL; PPAR gamma; Pulmonary Alveoli; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transforming Growth Factor beta | 2011 |
Metformin prevents the development of chronic heart failure in the SHHF rat model.
Topics: Animals; Blood Glucose; Blood Pressure; Chronic Disease; Gene Expression Regulation; Heart Failure; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Ventricular Remodeling | 2012 |
Rosiglitazone treatment reduces hippocampal neuronal damage possibly through alleviating oxidative stress in chronic cerebral hypoperfusion.
Topics: Animals; Chronic Disease; Hippocampus; Male; Neurons; Oxidative Stress; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2012 |
Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman.
Topics: Adult; Anxiety Disorders; Apgar Score; Atorvastatin; Chronic Disease; Diabetes Complications; Epilepsy; Female; Gliclazide; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Hypoglycemic Agents; Infant, Newborn; Obesity, Morbid; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Pyrroles; Rosiglitazone; Thiazolidinediones | 2004 |
PPAR-gamma agonist rosiglitazone ameliorates ventricular dysfunction in experimental chronic mitral regurgitation.
Topics: Animals; Chronic Disease; Dogs; Hemodynamics; Male; Mitral Valve Insufficiency; Myocardial Contraction; Myocytes, Cardiac; PPAR gamma; Rosiglitazone; Thiazolidinediones; Triglycerides; Ventricular Dysfunction, Left | 2005 |
Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin.
Topics: Adolescent; Adult; Aged; Cardiac Output, Low; Chronic Disease; Cohort Studies; Diabetes Mellitus, Type 2; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Retrospective Studies; Rosiglitazone; Thiazolidinediones | 2004 |
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces chronic colonic inflammation in rats.
Topics: Animals; Apoptosis; Chronic Disease; Colitis; Cyclooxygenase 1; Cyclooxygenase 2; Female; Immunohistochemistry; Male; Membrane Proteins; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Rosiglitazone; Thiazolidinediones | 2005 |